ARENA PHARMACEUTICALS INC's ticker is ARNAXXXX and the CUSIP is 040047102. A total of 1 filers reported holding ARENA PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $206,000 | +100.0% | 141,225 | +95.4% | 0.01% | +100.0% |
| Q4 2016 | $103,000 | +145.2% | 72,259 | +200.1% | 0.00% | +200.0% |
| Q3 2016 | $42,000 | -6.7% | 24,078 | -8.1% | 0.00% | 0.0% |
| Q2 2016 | $45,000 | -18.2% | 26,203 | -6.8% | 0.00% | 0.0% |
| Q1 2016 | $55,000 | -74.8% | 28,118 | -75.5% | 0.00% | -83.3% |
| Q4 2015 | $218,000 | +215.9% | 114,543 | +624.7% | 0.01% | +200.0% |
| Q1 2015 | $69,000 | -73.9% | 15,806 | -65.0% | 0.00% | -84.6% |
| Q4 2013 | $264,000 | – | 45,133 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SENZAR ASSET MANAGEMENT, LLC | 1,952,891 | $2,852,000 | 0.72% |
| Nine Chapters Capital Management LLC | 180,200 | $263,000 | 0.36% |
| Camber Capital Management LP | 4,250,000 | $6,205,000 | 0.25% |
| TFS CAPITAL LLC | 340,092 | $497,000 | 0.16% |
| ASCEND CAPITAL, LLC | 1,008,949 | $1,473,000 | 0.07% |
| Acrospire Investment Management LLC | 39,781 | $58,000 | 0.05% |
| OXFORD ASSET MANAGEMENT LLP | 1,081,912 | $1,580,000 | 0.04% |
| Jacobi Capital Management LLC | 35,000 | $49,000 | 0.02% |
| Renaissance Technologies | 8,479,445 | $12,380,000 | 0.02% |
| A.R.T. Advisors, LLC | 238,036 | $347,000 | 0.02% |